NRXP
NRX Pharmaceuticals, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website nrxpharma.com
- Employees(FY) -
- ISIN US6294442099
Performance
+20.82%
1W
-17.67%
1M
-24.81%
3M
+16.95%
6M
-23.04%
YTD
-47.93%
1Y
Profile
NRx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics that is in phase IIb/III clinical trials for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company has a joint Agreement with Nephron Pharmaceuticals, Inc. to develop intravenous ketamine to treat suicidal depression. The company was founded in 2015 and is based in Wilmington, Delaware.
Technical Analysis of NRXP 2024-05-10
Overview:
In analyzing the technical indicators for NRXP over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysis:
...Recent News & Updates
- 2024-05-14 08:57
- 2024-05-14 04:01
- 2024-05-07 21:55
- 2024-05-07 20:30
- 2024-05-07 04:01
- 2024-05-05 20:30
- 2024-04-29 20:30
- 2024-04-17 20:56
Why Is NRX Pharmaceuticals (NRXP) Stock Down 29% Today?(Investorplace)
- 2024-04-17 20:32
- 2024-04-17 20:30
- 2024-04-17 04:45
- 2024-04-16 20:30
- 2024-04-14 20:30
- 2024-04-07 20:30
- 2024-04-04 00:00
- 2024-04-01 22:33
- 2024-03-31 20:28
- 2024-03-28 10:53
- 2024-03-27 20:03
- 2024-03-27 20:00
- 2024-03-26 04:03
- 2024-03-24 20:30
- 2024-03-21 04:02
- 2024-03-21 01:57
- 2024-03-17 20:30
- 2024-03-11 19:49
- 2024-03-10 20:30
- 2024-03-03 19:30
- 2024-02-29 19:30
- 2024-02-26 21:49
/C O R R E C T I O N -- NRx Pharmaceuticals, Inc./(Yahoo Finance)
Page 1 of 5
previousnext